It is some ‘light at the end of the tunnel’ for residents of eastern Congo as WHO starts trials of a new Ebola treatment
The WHO announced the same day that the first participant had been enrolled in the study, which is evaluating whether the antiviral remdesivir, the experimental antibody treatment MBP134 or a combination of both can improve survival among patients infected with the Bundibugyo virus.
